Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model

Vorobiof, 2004, First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: a multicentre phase II study, Breast, 13, 219, 10.1016/j.breast.2004.01.006

Maier-Lenz, 1997, Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics, Semin Oncol, 24, 16

Pahl, 1999, Activators and target genes of Rel/NF-kappaB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239

Waddick, 1999, Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target, Biochem Pharmacol, 57, 9, 10.1016/S0006-2952(98)00224-X

Bian, 2001, NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells, J Biol Chem, 276, 48921, 10.1074/jbc.M108674200

Chuang, 2002, Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells, Biochem Pharmacol, 63, 1709, 10.1016/S0006-2952(02)00931-0

Yeh, 2002, Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation, Biochem Pharmacol, 63, 1423, 10.1016/S0006-2952(02)00908-5

Singh, 1995, Activation of transcription factor NF-κB is suppressed by curcumin (diferuloyl-methane), J Biol Chem, 270, 24995, 10.1074/jbc.270.42.24995

Jobin, 1999, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity, J Immunol, 163, 3474, 10.4049/jimmunol.163.6.3474

Plummer, 1999, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980

Kim, 2004, Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice, Clin Exp Metastasis, 21, 107, 10.1023/B:CLIN.0000024761.00373.55

Woronicz, 1997, IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK, Science, 278, 866, 10.1126/science.278.5339.866

Choi, 2001, FLASH coordinates NF-kappa B activity via TRAF2, J Biol Chem, 276, 5073, 10.1074/jbc.M102941200

Jones, 1999, Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas, J Pathol, 189, 161, 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2

Chang, 2001, The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis, Trends Cell Biol, 11, S37, 10.1016/S0962-8924(01)02122-5

Kuttan, 1985, Potential anticancer activity of turmeric (Curcuma longa), Cancer Lett, 29, 197, 10.1016/0304-3835(85)90159-4

Huang, 1988, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate, Cancer Res, 48, 5941

Tanaka, 1994, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene, Cancer Res, 54, 4653

Huang, 1994, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice, Cancer Res, 54, 5841

Singh, 1995, Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B, J Biol Chem, 270, 10631, 10.1074/jbc.270.18.10631

Anto, 2000, L-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosis, J Biol Chem, 275, 15601, 10.1074/jbc.C000105200

Huang, 1991, Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells, Proc Natl Acad Sci U S A, 88, 5292, 10.1073/pnas.88.12.5292

Liu, 1993, Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells, Carcinogenesis, 14, 857, 10.1093/carcin/14.5.857

Holy, 2002, Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells, Mutat Res, 518, 71, 10.1016/S1383-5718(02)00076-1

Li, 1999, Antitumor activity of poly(l-glutamic acid)-paclitaxel on syngeneic and xenografted tumors, Clin Cancer Res, 5, 891

Shishodia, 2003, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1, Carcinogenesis, 24, 1269, 10.1093/carcin/bgg078

Shishodia, 2005, Curcumin (diferuloylmethane) inhibits constitutive NF- κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma, Biochem Pharmacol, 70, 700, 10.1016/j.bcp.2005.04.043

Aggarwal, 2005, Curcumin suppresses the paclitaxel-induced NF- κB in breast cancer cells and inhibits lung metastasis of human breast cancer cells in nude mice, Clin Cancer Res, 11, 7490, 10.1158/1078-0432.CCR-05-1192